1. Home
  2. NAZ vs CGEN Comparison

NAZ vs CGEN Comparison

Compare NAZ & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAZ
  • CGEN
  • Stock Information
  • Founded
  • NAZ 1992
  • CGEN 1993
  • Country
  • NAZ United States
  • CGEN Israel
  • Employees
  • NAZ N/A
  • CGEN N/A
  • Industry
  • NAZ Finance/Investors Services
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NAZ Finance
  • CGEN Health Care
  • Exchange
  • NAZ Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • NAZ 145.2M
  • CGEN 125.3M
  • IPO Year
  • NAZ N/A
  • CGEN 2000
  • Fundamental
  • Price
  • NAZ $11.85
  • CGEN $1.54
  • Analyst Decision
  • NAZ
  • CGEN
  • Analyst Count
  • NAZ 0
  • CGEN 0
  • Target Price
  • NAZ N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • NAZ 18.3K
  • CGEN 278.8K
  • Earning Date
  • NAZ 01-01-0001
  • CGEN 11-10-2025
  • Dividend Yield
  • NAZ 3.69%
  • CGEN N/A
  • EPS Growth
  • NAZ N/A
  • CGEN N/A
  • EPS
  • NAZ N/A
  • CGEN N/A
  • Revenue
  • NAZ N/A
  • CGEN $6,903,000.00
  • Revenue This Year
  • NAZ N/A
  • CGEN N/A
  • Revenue Next Year
  • NAZ N/A
  • CGEN $208.08
  • P/E Ratio
  • NAZ N/A
  • CGEN N/A
  • Revenue Growth
  • NAZ N/A
  • CGEN N/A
  • 52 Week Low
  • NAZ $9.22
  • CGEN $1.13
  • 52 Week High
  • NAZ $11.37
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • NAZ 47.75
  • CGEN 40.53
  • Support Level
  • NAZ $11.77
  • CGEN $1.55
  • Resistance Level
  • NAZ $11.95
  • CGEN $1.66
  • Average True Range (ATR)
  • NAZ 0.15
  • CGEN 0.11
  • MACD
  • NAZ -0.01
  • CGEN -0.02
  • Stochastic Oscillator
  • NAZ 30.49
  • CGEN 0.47

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: